PMA P250041

Device
SELUTION SLR™ 014 PTCA Drug-Eluting Balloon
Applicant
MedAlliance, LLC
PMA number
P250041
Supplement
S001
Product code
OOB
Decision date
2026-11-06
Classification
Cardiovascular
Generic name
Drug-eluting percutaneous transluminal coronary angioplasty catheter
Approval order statement
SELUTION4ISR Continued Follow-up Study will evaluate the long-term safety and effectiveness of the SELUTION SLR PTCA DEB in 418 subjects from the premarket study (SELUTION4ISR). Subjects will be followed annually through 5 years post-procedure, and all efforts will be made to minimize the amount of missing long-term data.

Current openFDA PMA Record#

Device
SELUTION SLR™ 014 PTCA Drug-Eluting Balloon
Applicant
MedAlliance, LLC
PMA number
P250041
Supplement
S001
Product code
OOB
Generic name
Drug-eluting percutaneous transluminal coronary angioplasty catheter
Decision date
2026-11-06
Decision code
APPR
Date received
2026-10-08
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Approval order statement
SELUTION4ISR Continued Follow-up Study will evaluate the long-term safety and effectiveness of the SELUTION SLR PTCA DEB in 418 subjects from the premarket study (SELUTION4ISR). Subjects will be followed annually through 5 years post-procedure, and all efforts will be made to minimize the amount of missing long-term data.